Guardant Health, Inc. ( GH) - Key Metrics
GH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.19 | -$1 | -$0.11 | -$0.33 |
| 2025Q3 | $2.12 | -$0.74 | -$0.28 | -$0.37 |
| 2025Q2 | $1.87 | -$0.80 | -$0.49 | -$0.53 |
| 2025Q1 | $1.64 | -$0.77 | -$0.51 | -$0.54 |
GH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -25.57 |
| 2025Q3 | ? | -21.02 |
| 2025Q2 | ? | -16.16 |
| 2025Q1 | ? | -13.86 |
GH Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.59% | ? |
| 2025Q4 | -0.32% | ? |
| 2025Q3 | -0.59% | ? |
| 2025Q2 | -1.02% | ? |
| 2025Q1 | -1.27% | ? |
GH
Price: $152.29
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.40 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 409714
Market Capitalization: 22.3 billion